The Needle Syringe Program National Minimum Data Collection (NSP NMDC) supports the National Strategies for blood borne and sexually transmissible infections and complements the annual Australian Needle Syringe Program Survey National Data Report.
This discussion paper provides a background on long-acting injectable Cabotegravir (CAB-LA) for HIV pre-exposure prophylaxis (PrEP). The paper outlines research priorities for implementing CAB-LA in Australia and was used to consult with Australian HIV Stakeholders. Findings from the Kirby Institute at UNSW Sydney, and Alfred Health in Melbourne, are reported on a range of formative research that investigated preferences and opinions of CAB-LA from community members, HIV stakeholders, and service providers.
This report summarises data on the prescription and distribution of hepatitis C treatments and provides insight into the initial phase of the roll-out of DAA therapy in Australia.
The report describes opinions of vaccines, the social processes that drive or inhibit vaccination, the practical factors that act as facilitators and barriers to vaccination, among Australian gay and bisexual men. The report also makes recommendations for promotional messaging to maximise vaccine uptake.
The first report to provide an account of progress of hepatitis C elimination among Aboriginal and Torres Strait Islander people as framed by global and national strategies. Progress is measured by service coverage indicators (including hepatitis C testing and treatment; harm reduction coverage) and impact targets (including new hepatitis C infections; hepatitis C related morbidity and mortality). An estimate of the hepatitis C cascade of care, including the number of Aboriginal and Torres Strait Islander people with chronic hepatitis C at end 2020 is provided.
The RISE Study utilises longitudinal, semi-structured interviews to explore the experiences of people recently diagnosed with HIV in Australia, including life after diagnosis. To date, 28 people living with HIV have taken part in interviews, with over three-quarters having completed a follow-up interview. Issues including sex and HIV prevention prior to diagnosis, the clinical diagnosis experience, access to and use of HIV clinical care and peer support services, disclosure, sex, relationships, and impacts of COVID-19 are explored.
This report summarises data on the prescription and distribution of hepatitis C treatments and provides insight into the initial phase of the roll-out of DAA therapy in Australia.
This project used semi-structured interviews to explore the experiences of 24 overseas-born gay and bisexual men (GBM) recently diagnosed with HIV. In recent years, HIV notifications among this sub-population of GBM have increased. To respond effectively, focused attention is needed on the practices and beliefs of this sub-population. The objective of this project was to characterise the key factors and barriers contributing to new HIV diagnoses among this group.
The NSW Aboriginal Sexual and Reproductive Health (SRH) Program was a NSW Ministry of Health initiative which aimed to increase Aboriginal youth’s (aged 12–19 years) access to sexual and reproductive health programs through health promotion initiatives delivered by Aboriginal Sexual and Reproductive health workers based in seven Aboriginal Community Controlled Health Services (ACCHSs) and one Local Health District across NSW.
A reorientation of the original Flux (Following Lives Undergoing Change) Study, this report summarises baseline data collected from 913 gay and bisexual men (GBM) during April 2020 on the impacts of COVID-19 and physical distancing measures. We reported findings on sexual behaviours, use of pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP), drug use, mental health, testing for COVID-19 and social connectedness among GBM in Australia in the early stages of the pandemic.
